Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-35,341
Closed -$2.71M – 656
2019
Q3
$2.71M Sell
35,341
-8,094
-19% -$708K 0.02% 366
2019
Q2
$3.73M Buy
43,435
+24,056
+124% +$1.64M 0.02% 341
2019
Q1
$1.15M Buy
19,379
+5,678
+41% +$327K 0.01% 509
2018
Q4
$723K Buy
+13,701
New +$804K ﹤0.01% 547
2016
Q3
– Sell
-36,808
Closed -$1.01M – 559
2016
Q2
$1.01M Sell
36,808
-5,779
-14% -$148K ﹤0.01% 394
2016
Q1
$1.14M Sell
42,587
-2,074
-5% -$50.8K ﹤0.01% 394
2015
Q4
$1.26M Buy
44,661
+36,526
+449% +$1.05M 0.01% 402
2015
Q3
$227K Buy
+8,135
New +$294K ﹤0.01% 489

Other funds holding RGEN

AJO LP's RGEN Position: Q4 2019 in Review

AJO LP sold out of Repligen (RGEN) in Q4 2019, closing a stake of 35,341 shares — an estimated $2.71M sold.

AJO LP first reported a position in RGEN in Q3 2015 and held it in 8 quarters. The position peaked at $3.73M in Q2 2019. 306 funds tracked by Wall St. Rank hold RGEN as of Q4 2019.

  • AJO LP reported no remaining Repligen position as of Q4 2019 after selling out during the quarter.
  • AJO LP sold 35,341 Repligen shares in Q4 2019, an estimated $2.71M.
  • AJO LP first reported a position in Repligen in Q3 2015 and held it in 8 quarters.
  • AJO LP's Repligen position peaked at $3.73M in Q2 2019.
  • 306 funds tracked by Wall St. Rank held Repligen as of Q4 2019.

Based on AJO LP's 13F filing for Q4 2019, filed 12 Feb 2020.